Floatz logo

Cyclophosphamide

AML/MDS

St. Jude Children's Research HospitalSmall moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

10 Active assets in the AML/MDS cohort.

Asset / SponsorPhaseRating
Midostaurin
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2CCC
Decitabine
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2CCC
Azacitidine
Newave Pharmaceutical Inc
Phase 1CC
lp-108
Newave Pharmaceutical Inc
Phase 1CC
Fludarabine
Senti Biosciences
Phase 1CC

View all 13 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →